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Alternative splicing: The production of mature mRNAs that varies in sequence
composition because of the use of different splices during the maturation of
each transcript. Resulting transcripts can differ by the inclusion of cassette
exons or terminal exons, usage of alternative splice sites of variable-length
exons or intron retention.
Branch point: A splicing signal located in the intron upstream of the 30 splice
site. It contains an adenine, which is ligated to the 50 splice site ribonucleotide
to form the intron lariat.
Cassette exon: An exon that is included or skipped as one unit during
alternative splicing.
Isoform: A mature mRNA representing one of multiple variations that can be
created by alternative splicing.
RNA-seq: A method to analyse the transcriptome by reverse transcribing
mRNAs into a cDNA library, which is sequenced by high-throughput
sequencing. If the number of sequencing reads is sufficient, it can be used to
evaluate alternative splicing.
Pre-mRNA: An RNA transcript as it is synthesised by RNA polymerase II, before
intron removal via RNA splicing.
RNA riboswitch: An RNA sequence that changes its structure upon the binding
of specific, small molecules. The change in RNA structure most often plays a
role in regulating the expression of the resident mRNA.
Splice-junction microarrays: A microarray specifically designed to assay
alternative splicing by probes (short sequences) that anneal to alternative
exons and splice junctions.
50 splice site: Highly conserved sequence at the 50 end of the intron. During the
first step of splicing, it undergoes nucleophilic attack from the 20-OH of the
branch point to form the intron lariat.
30 splice site: Highly conserved sequence at the 30 end of the intron. During the
second step of splicing, it undergoes nucleophilic attack from the 30-OH of theAlternative splicing is a highly regulated process that
greatly increases the proteome diversity and plays an
important role in cellular differentiation and disease.
Interactions between RNA-binding proteins (RBPs) and
pre-mRNA are the principle regulator of splicing deci-
sions. Findings from recent genome-wide studies of
protein–RNA interactions have been combined with
assays of the global effects of RBPs on splicing to create
RNA splicing maps. These maps integrate information
from all pre-mRNAs regulated by single RBPs to identify
the global positioning principles guiding splicing regu-
lation. Recent studies using this approach have identi-
fied a set of positional principles that are shared between
diverse RBPs. Here, we discuss how insights from RNA
splicing maps of different RBPs inform the mechanistic
models of splicing regulation.
Studying alternative splicing using genome-wide
approaches
Technological advances in the past decade have created the
unprecedented ability to explore alternative splicing in a
genome-wide manner. As the depth of analysis has in-
creased, the estimated proportion of human genes that
produce alternative mRNA isoforms has increased, from
35% in 1999 [1] to 94% in 2008 [2]. Splicing defects have
been associated with many human diseases [3,4], and
studies of the regulatory programmes that control splicing
decisions have already revealed clues to the causes of
several human diseases and identified splicing targets
for RNA therapeutics [5,6]. Many diseases, however, might
be affected by splicing regulatory errors in ways that have
yet to be understood [7].
There are many ways to regulate alternative splicing.
RNA–RNA interactions between distal sites are important
for the regulation of mutually exclusive exons of the Down
syndrome adhesion molecule (Dscam) transcript in Dro-
sophila melanogaster [8]. This intricate regulation is par-
ticularly important because of the complex splicing of the
Dscam transcript, which contains three clusters of 12, 48
and 33 mutually exclusive exons that can theoretically
generate 38016 different alternative isoforms. A small
molecule binding to an RNA riboswitch affects alternative
splicing in the fungus Neurospora crassa by inducing
changes in pre-mRNA structure [9]. Pre-mRNA interac-
tions with noncoding RNAs, including a small nucleolar
RNA [10] and an RNA related to 5S ribosomal RNA [11],
have also been reported. Despite this potential diversity ofCorresponding author: Ule, J. (jule@mrc-lmb.cam.ac.uk).
0168-9525  2010 Elsevier Ltd. All rights reserved. doi:10.1016/j.tig.2010.12.001regulatory mechanisms, protein–RNA interactions are
considered the primary elements of splicing regulation
and these interactions will be the focus of the remainder
of this review.
Genome-wide studies play a key role in understanding
the regulation of alternative splicing in disease and normal
physiology. Initial bioinformatic studies have identified
putative regulatory RNA motifs by comparing exons with
different splice site strengths [12] or by comparing exons to
pseudoexons [13]. Later studies have used the genome-
wide data generated by splice-junction microarrays or
RNA-seq to compare RNA motifs that are enriched near
alternative exons with splicing patterns specific to tissues
[2,14,15] or particular stages of differentiation [16,17] or
disease [3,18]. Bioinformatic studies have also directly
evaluated the importance of protein–RNA interactions in
regulating splicing choices. This was achieved by analysing
the presence of RNA motifs recognized by specific RNA-
binding proteins (RBPs) near alternative exons. This ap-
proach was used to predict alternative exons regulated by
serine/arginine-rich (SR), Nova and Fox proteins among
others [19–22]. For instance, the evidence for the global
role of Fox proteins in tissue-specific splicing regulation50 exon, leading to the release of the intron and the joining of the two exons.
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Box 1. Methods using UV crosslinking for genome-wide
studies of protein–RNA interactions
CLIP (UV crosslinking and immunoprecipitation): Exposure to UVC
light creates a covalent bond between proteins and the RNA to
which they are bound. This physical link is used to isolate the RNAs
bound by a specific protein using immunoprecipitation and
denaturing gel electrophoresis. The protein is then digested, and
the RNA is prepared for sequencing using the sequential ligation of
two RNA adapters to prepare the cDNA library [24]. The short length
of CLIP cDNA sequences is perfectly compatible with high-
throughput sequencing and is referred to as HITS-CLIP (high-
throughput sequencing CLIP) or CLIP-seq [32,38,42,76]. Unlike
standard CLIP, PAR-CLIP (photoactivatable ribonucleoside-en-
hanced CLIP) incorporates 4-thiouridine into RNAs to generate
protein–RNA crosslinks using UVA light, which has been claimed to
increase crosslinking efficiency [76]. Related methods have been
developed for situations in which it is not possible to isolate the
native protein because of the lack of a specific antibody or if
individual protein domains need to be studied. These methods
include the affinity purification of proteins in yeast (UV crosslinking
and cloning – CRAC) [77] and the affinity purification of tagged
proteins in cell lines (UV crosslinking and affinity purification –
CLAP) [41].
iCLIP (individual nucleotide resolution CLIP) isolates RNAs that
are crosslinked to specific proteins as in standard CLIP. After protein
digestion, an amino acid (or a short peptide) remains at the RNA
crosslink site, which leads to the frequent truncation of cDNAs
previously exploited to map crosslink sites using primer extension
assays [78]. Using cDNA circularization to prepare the cDNA library
allows for the high-throughput sequencing of cDNAs that truncate at
that peptide [40]. Sequencing truncated cDNAs identifies the
protein–RNA crosslink site with high resolution. The use of random
barcodes to mark cDNAs during library preparation makes it
possible to determine if identical sequences arose from multiple
independent cDNAs or are the result of PCR amplification. These
barcodes, therefore, help preserve the quantitative nature of the
cDNA library.
Review Trends in Genetics March 2011, Vol. 27, No. 3came from the enrichment of their binding motif
(U)GCAUG near exons with brain or muscle-specific splic-
ing patterns [2,14,23]. Similarly, the enrichment of this
motif near exons with splicing changes in breast and
ovarian tumours revealed a role for Fox proteins in human
disease [3].
The pre-mRNA sequence elements required for in vivo
splicing regulation have also been identified experimental-
ly. Even though these elements most often map to intronic
regions that are rapidly degraded upon splicing comple-
tion, they can be identified by the analysis of protein–RNA
interactions using UV crosslinking and immunoprecipita-
tion (CLIP; Box 1). CLIP data provided the first evidence
for the global role of Nova proteins in brain-specific splicing
regulation [24]. Below, we discuss the recent progress
made by genome-wide studies and describe how combining
protein–RNA interaction information with genome-wide
splicing analyses can reveal global principles behind splic-
ing regulation.
RNA splicing map: an integrative approach to study
splicing regulation
Early studies of splicing regulation indicated that SR
proteins enhance exon inclusion, whereas heterogeneous
nuclear ribonucleoproteins (hnRNPs) silence exon inclu-
sion by antagonising the SR proteins [25]. This conclusion
was supported by splicing minigene reporter studies of a
small number of exons, which showed that SR proteins90enhance exon definition by strengthening interactions be-
tween spliceosome components and the pre-mRNA, where-
as hnRNPs block such interactions [26]. However,
exceptions to this rule were found [26]. For instance, SR
proteins normally enhance splicing by binding within the
exon, but were found to repress splicing in the adenovirus
L1 unit when bound to an upstream intron [27]. hnRNP L
protein binding close to an alternative 50 splice site led to
silencing, whereas binding further downstream enhanced
exon inclusion [28]. Similarly, Nova binding within an
alternative exon led to silencing, but binding downstream
enhanced exon inclusion [29]. These studies indicated that
the positions of protein–RNA interactions play amajor role
in splicing regulation, although it was not known whether
the position-dependent splicing effects were unique to each
target RNA or if they represented general principles of
splicing regulation that were common to different RNAs
and, possibly, different RBPs.
To understand the general principles of splicing regula-
tion, it is necessary to identify protein–RNA interactions
with high resolution in a genome-widemanner. However, a
single genome-wide data set rarely provides significant
insight into splicing regulation on its own. Partly, this is
because protein-binding sites are most often located far
from alternative exons, as shown by the first analyses of
Nova–RNA interactions using CLIP [24]. In addition, the
RNA motifs recognised by RBPs are often degenerate and,
therefore, expected to occur frequently in pre-mRNAs. For
example, Nova proteins recognise the motif YCAY (Y
represents either pyrimidine base) usually in clusters of
multiple tetramers [30]. Many of these motifs can lead to
high-affinity protein–RNA interactions that are nonfunc-
tional. Furthermore, protein–RNA interactions are known
to have roles in the regulation of other post-transcriptional
processes, such as processing microRNA precursors or the
30 end of mRNAs [31,32]. Therefore, analysis of genome-
wide protein–RNA interactions alone is not sufficient to
study the positional principles behind splicing regulation.
The success of genome-wide studies lies in the integra-
tion of multiple, independent data sets [4]. Combining
genome-wide protein–RNA interaction sites with the anal-
ysis of splicing profiles allows the analysis of RNA splicing
maps, which determine the position-dependent regulatory
effects of protein–RNA interactions (Figure 1a). Originally
referred to as an ‘RNA map’ [20], the term ‘RNA splicing
map’ is preferred here to distinguish it from analyses of the
position-dependent regulation of other aspects of RNA
processing. The initial approach used with Nova proteins
combined bioinformatically identified Nova-binding sites
with splicing profiles identified by splice-junction micro-
arrays [20,33] (Figure 1b). A similar RNA splicingmapwas
obtained later when protein–RNA interaction sites were
determined experimentally by the high-throughput se-
quencing of CLIP [32] (Figure 1c). Moreover, instead of
splice-junction microarrays, splicing profiles can now be
derived from RNA-seq data [34] (Figure 1d). These three
RNA splicing maps are not identical, which is expected
because of the different methods used to derive them.
However, in spite of this variability, the three maps
detected the same primary positions of enriched Nova
binding.
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Figure 1. Schematic procedure for generating an RNA splicing map. (a) RNA splicing maps are generated by integrating RBP-binding data and splicing profiles. A variety of
methodologies can provide this information depending on the model system, technology available and research goals. The simplest form of an RNA splicing map
summarises the effects of RBP (ellipses) binding on a cassette exon. Exons are separated into those enhanced (red line) or silenced by the RBP (blue line), and control exons,
which are not regulated by the RBP. To find positional principles of splicing regulation, RBP-binding data are combined for each group of exons into a hypothetical,
composite cassette exon, with a focus on positions surrounding (typically within 200 base pairs) the 50 and 30 splice sites (50 SS and 30 SS), the potential branch points of the
alternative exon (green box) and the flanking exons (grey boxes). (b) A Nova RNA splicing map for cassette exons generated by integrating the bioinformatic identification
of Nova-binding sites and splice-junction microarray data (reproduced with permission from [20]). (c) A Nova RNA splicing map for cassette exons generated by integrating
the HITS-CLIP experimental identification of Nova-binding sites and splice-junction microarray data (reproduced with permission from [32]). (d) An RNA splicing map for
Pasilla, the Drosophila orthologue of Nova, generated by integrating the bioinformatic identification of Pasilla-binding sites and splicing profiles from RNA-seq data
(reproduced with permission from [34]). As shown for the Nova RNA splicing maps in (b) and (c), Pasilla-binding sites are most enriched within and immediately upstream
of the skipped exons (blue line) and downstream of enhanced exons. The distance relative to the closest splice site is shown underneath each map. The position of RBP
binding is shown on the x-axis. The frequency of RBP binding is shown on the y-axis in red for enhanced, blue for silenced and black for control exons.
Review Trends in Genetics March 2011, Vol. 27, No. 3Studies of the polypyrimidine tract-binding protein
(PTB) illustrate the need for independent protein–RNA
interaction and splicing data sets when building RNA
splicing maps. Initially, CLIP data were used to identify
interaction sites and select target exons to collect splicing
data by RT-PCR analysis. This RNA splicing map indicat-
ed that PTB primarily silences exon inclusion when bound
downstream of exons [35]. When PTB-regulated exons
were identified independently by microarray, the RNA
splicing map indicated that PTBmore often enhances exon
inclusion when bound downstream of exons [36]. Thus, the
integration of independent genome-wide data sets is re-
quired to identify general principles of splicing regulation.
RNA splicing maps reveal general principles of splicing
regulation
The similarity of the RNA splicingmaps of themouse Nova
and of Pasilla, the Drosophila orthologue of Nova, shows
that position-dependent regulatory effects are highly con-
served [34]. Common principles can be identified by com-
paring the RNA splicing maps of different RBPs that have
been derived so far [18,20,21,32,35–41] (Figure 2). Surpris-
ingly, a comparison of these RNA splicing maps reveals
that RBPs share many common positional principles [42].
Nova, hnRNP C, L and H, Fox, PTB, and muscleblind
(Mbnl1) silence exon inclusion by binding at positions close
to the branch points, splice sites or within exons
(Figure 2a). By contrast, Nova, hnRNP L, Fox, PTB, Mbnl1and TIA proteins enhance exon inclusion by binding down-
stream of exons (Figure 2b).
The RNA splicing maps of hnRNP C and TIA proteins
appear more restricted than other RBPs. hnRNP C exclu-
sively silences exon inclusion when binding near the alter-
native exon (Figure 2a). By contrast, TIA proteins only
bind downstream of exons (Figure 2b). What could be the
reason for such restricted activity? hnRNP C binds RNA as
a homo-tetramer and assembles into higher-order hnRNP
particles on long RNAs [43]. Tetramer binding at multiple
sites both upstream and downstream of the exon might
allow the silencing of exon inclusion [40]. Silencing effects
involving multiple binding sites was first observed for Sex-
lethal and PTB using minigene reporters [44,45]. Binding
at exon flanking sites has been shown to promote repres-
sive RNA looping and interfere with interactions between
the spliceosome components [46,47].
TIA proteins enhance exon inclusion when binding
downstream of alternative exons, with no evidence for
silencing when binding to other sites near the alternative
exons [41]. Exclusive binding downstream of exons cannot
be predicted from pre-mRNA sequences. Uridine-rich
motifs, which TIA proteins bind with high affinity, are
equally frequent upstream and downstream of exons
[48]. TIA proteins interact with U1 small nuclear ribonu-
cleoprotein (snRNP), the spliceosome component required
for the recognition of the 50 splice site and initiation of
splice site pairing [49]. The yeast orthologue of TIANam8p91
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Figure 2. Shared positional effects identified by the RNA splicing maps of different RBPs. (a) Positions in silenced exons with the enriched binding of different RBPs. Shown
above the transcript diagram, RBP (blue ellipse) binding to a single site close to 30 SS silences exon inclusion (blue line). Even though not shown in this diagram, such a site can
also lie within the exon or close to the 50 SS. Shown below the transcript diagram, some RBPs bind at intronic positions close to 30 and 50 splice sites of the exon to efficiently
silence exon inclusion. The arrows indicate that binding at the different positions is achieved by the different RBPs or a hnRNP C. (b) Positions of enhanced exons with the
enriched binding of different RBPs. Shown above the transcript diagram, RBP (red ellipse) binding downstreamof the 50 splice site of a cassette exon promotes its inclusion (red
line). Shown below the transcript diagram, RBP binding at multiple positions at both ends of the downstream intron enhances exon inclusion. The arrows indicate that
interaction between the RBPs bound at both sides of the intronmight be required for the enhancing effect. In contrast to the RBPs studied so far, SR proteins enhance inclusion
when bound within exons. Upstream and downstream exons (grey boxes) and potential branch points (yellow boxes) are also indicated for positional reference.
Review Trends in Genetics March 2011, Vol. 27, No. 3is a core component of U1 snRNP [50]. The evolutionary
conservation of TIA interaction with U1 snRNP suggests
that the TIA–U1 snRNP complex might restrict TIA bind-
ing to positions downstream of exons. Taken together, the
close association of hnRNP C and TIA proteins with de-
fined higher-order complexes might be the reason for their
more restricted position-dependent effects compared with
other RBPs.
The role of RBPs in intron definition
The in vitro and in vivo analysis of introns that require
hnRNP A1 or hnRNP H for efficient splicing showed that
these proteins need to bind both ends of the intron to
stimulate splicing [51] (Figure 2b). Similarly, the Nova92RNA splicing map indicated that Nova often enhances
exon inclusion by binding at both ends of the downstream
intron. In half of the exons with Nova binding immediately
downstream of the exon, an additional Nova binding site is
present close to the branch point of the intron, suggesting
that the enhancing activity involves Nova binding the two
sites at each end of the intron [20]. These effects can be
explained by the intron definition model, which suggests
that RBPs bound at both sides of an intron can interact to
promote an RNA loop that brings the 50 splice site in
proximity to the branch point.
Heterotypic interactions between hnRNP A1 and
hnRNP H could stimulate splicing by promoting RNA
looping [52]. Similarly, conserved sequences around No-
Review Trends in Genetics March 2011, Vol. 27, No. 3va-regulated exons suggest a functional interaction be-
tween the binding sites of Fox and Nova proteins when
they bind to the two sides of an intron [22] (Figure 2b).
These results indicate that homotypic and heterotypic
interactions between RBPs bound to distal sites on pre-
mRNAs might be a widespread mechanism for splicing
regulation. As CLIP data for more RBPs become available,
many more interactions between RBPs that regulate splic-
ing by promoting pre-mRNA looping might be revealed.
Global principles, specific mechanisms?
What do the common principles identified by RNA splicing
maps tell us about the mechanisms of splicing regulation?
The RBPs that share positional principles are not homolo-
gous to each other. Often they bind RNA with different
domains such as KH in Nova, zinc finger in Mbnl and RRM
in the other RBPs discussed above. The silencing effects,
when binding near the branch point, splice sites or within
the exon, could be explained by competition with core
spliceosome components or SR proteins [20,25,26]. Expla-
nation of the enhancing effects, when RBPs bind down-
stream of exons, is more challenging. These proteins might
enhance exon inclusion by directly interacting with and
stabilising U1 snRNP on the pre-mRNA. Alternatively,
they might interact with TIA proteins to stabilize a
TIA–U1 snRNP complex. They could also act by altering
the RNA structure in amanner that increases the ability of
the U1 snRNP to interact with the 50 splice site. Lastly, as
discussed above, they might form homotypic or heterotypic
interactions that promote intron definition. Detailed bio-
chemical studies will be required to unravel these mechan-
isms or possibly uncover new explanations for these shared
positional principles.
Further analyses of RNA splicing maps and other RBPs
are likely to identify global, position-based splicing effects
that differ from those determined so far. For example, SR
proteins enhance exon inclusion by bindingwithin the exon[()TD$FIG](a) Fast splicing kinetics
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Figure 3. The distal regulation of variable-length exons by TIA proteins. (a) TIA protein
(yellow ellipse) binding, thereby potentially increasing the rate of transition from the H
faster splicing kinetics. This reduces the time available for RBPs, such as SR proteins
exclusion (thick blue line) of the variable region (green box) relative to inclusion (thin
proteins, the reduced stability of U1 snRNP binding might slow splicing kinetics and
transcript. For example, the binding of additional SR proteins (marked by a question m
preferential inclusion (thick red line) of the variable region of the exon. The blue line rep
lines represents the extent of the splicing choice.[53], in contrast to the silencing effects of other RBPs
(Figure 2b). Even though the binding sites for SR proteins
are enriched in exons, they also bind to introns [19,54–56].
The RNA splicing maps of SR proteins could, therefore,
provide new insight into their position-based splicing
effects. Furthermore, given that homotypic and heterotyp-
ic protein–protein interactions can change the conforma-
tion of pre-mRNA to either silence or enhance exon
inclusion [22,46,47,51,52], many combinatorial possibili-
ties remain to be explored. Combinatorial RNA splicing
maps might help identify new interactions between RBPs
that regulate splicing through the modification of the pre-
mRNA structure.
Splicing effects of distal TIA binding suggest a role of
splicing kinetics
Above, we discussed the splicing effects of RBP binding
sites proximal to alternative exons. The analysis of CLIP
data and RNA splicing maps also suggests that RBPs can
regulate splicing when binding only at positions distal to
alternative exons [20,24,32,35,40,41]. Indeed, the Nova
RNA splicing map indicates that Nova proteins can silence
the inclusion of an alternative exon when binding close to
the preceding exon [20].
Recently, TIA proteins, like Nova proteins, were found
to silence exon inclusion when binding to the preceding
exon [41]. In addition to silencing the distal cassette exons,
TIA proteins are also able to silence distal alternative 30
splice sites by binding at the preceding exon (Figure 3),
showing that TIA could achieve a distal splicing effect
withoutmodulating competition betweenmultiple 50 splice
sites. One possible explanation for this distal effect is that
TIA acts by affecting the kinetics of the splicing reaction.
The splicing reaction proceeds through three stages before
splice site pairing is committed [57]. In the first stage,
referred to as H complex, RBPs assemble on the pre-
mRNA. In the next stage, referred to as E complex, theSR
SRSR?
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Review Trends in Genetics March 2011, Vol. 27, No. 3U1 snRNP and SR proteins assemble on the splice sites
and within the exons. In the third stage, referred to as A
complex, the branch point is recognized by the second
spliceosome component the U2 snRNP, which leads to
splice site pairing and commitment to a specific splicing
choice [57]. TIA proteins might increase the rate of transi-
tion from the H complex to the A complex by enhancing the
U1 snRNP recruitment to the 50 splice site of the preceding
exon. This would restrict the temporal window available
for other RBPs to assemble on the alternative exon and
thereby influence the splicing choice. Because the effects of
distal TIA binding are associated with silencing, such a
model would suggest that this temporal window primarily
affects the assembly of RBP complexes that enhance exon
inclusion, such as SR proteins [41] (Figure 3).
Integration of multiple variables into splicing decisions
Splicing decisions result from the integration of multiple
variables, primarily changes in the expression of RBPs,
changes in RBP activity because of signalling pathway-
induced post-translational modifications [58] and changes
in transcription or chromatin [59]. Promoter identity [60],
transcriptional elongation [61] and chromatin modifica-
tions [62–64] can all affect the splicing of specific alterna-
tive exons. Splicing factors accumulate on nascent
transcripts as the RNA polymerase synthesises the pre-
RNA [65–67]. The comparison of splicing intermediates in
the chromatin and nucleoplasm indicates that splicing is
largely completed before the release of the transcript from
the chromatin template [68]. These observations underlie
several models to explain how the coupling of splicing to
transcription and chromatin affects splicing choices.
The recruitment model proposes that certain splicing
regulators, particularly those containing arginine-rich,
positively charged regions (such as SR proteins), bind
the hyperphosphorylated, negatively charged C-terminal
domain of elongating RNA polymerase II (Pol II CTD) [69].
In support of this model, antibodies against Pol II CTD
coimmunoprecipitate SR proteins. Furthermore, the local-
ization of SR proteins to sites of transcription and the
activity of certain SR proteins also require Pol II CTD
[61,70]. Interestingly, studies have suggested that in addi-
tion to Pol II CTD chromatin might also play a role in
recruiting RBPs. Specific modifications of histone 3 have
been shown to recruit U2 snRNP components or PTB to
nascent transcripts [64,71]. Whether Pol II CTD and chro-
matin recruit RBPs to the nascent transcripts in a se-
quence-independent manner, or only increase the local
concentration of RBPs on chromatin, remains to be re-
solved.
Chromatin immunoprecipitation experiments have
shown that the treatment of formaldehyde crosslinked cell
lysate with RNase releases SR proteins from the FOS gene
[70]. This indicates that interactions between SR proteins
and Pol II are dependent on nascent RNA, rather than SR
proteins being recruited to the RNA via interactions with
Pol II. In such a case, an alternative model is necessary to
explain how transcription modulates splicing. The first-
come first-served model proposes that the speed of tran-
scriptional elongation directly affects the splicing of cas-
sette exons, such that slow elongation gives the upstream94intron additional time to be spliced before the downstream
intron becomes available [72]. This model was recently
evaluated by analysing the splicing intermediates of fibro-
nectin exon 33, where one flanking intron was spliced and
the other remained unspliced [68,73]. This study showed
that the downstream intron is spliced before the upstream
intron, even in conditions of slow transcriptional elongation.
Even though splicing intermediates do not necessarily
reflect the order of intronic commitment to splicing [73],
faster splicing of the downstream intron is not easily
compatible with the first-come first-served model.
Finally, the splicing kinetics model proposes that the
temporal window available for RBP assembly on nascent
transcripts can affect splicing choice. This temporal win-
dow is determined by the kinetics of transition from the H
to A splicing complexes. This model was first proposed to
explain the effect of an elongation-defectivemutant of RNA
Pol II on the splicing of alternative 50 splice sites in the
adenovirus E1a gene [72]. Owing to the alternative 50
splice sites being in close proximity to each other, their
regulation could not be explained by the first-come first-
served model. Instead, slower transcription elongation
might allow more time for RBPs and splicing machinery
to assemble on the nascent transcript before the 30 splice
site becomes available to pair with the 50 splice sites
[59,72]. As discussed earlier, this splicing kinetics model
could also explain the ability of TIA proteins to modulate
splicing choices from distal sites (Figure 3). Thus, the
splicing kinetics model could explain the splicing effects
of many different factors, as long as these factors can
change the temporal window available for RBP complexes
to assemble on the nascent transcript before the splicing
choice is made.
Asymmetric decision making in alternative splicing
To conceptualise how RBP binding at different positions
affects splicing decisions, we can consider the splicing
decision as a competition between commitment to three
possible splicing pathways: exon skipping, upstream in-
tron splicing and downstream intron splicing. The up-
stream and downstream intron splicing pathways both
lead to exon inclusion. Splicing intermediates in Nova1–/–
Nova2–/– brains have shown that the splicing effects of
Nova proteins are restricted to the intron containing the
Nova-binding sites [20]. Importantly, the intron containing
the Nova-binding site is generally spliced first, indicating
that RBP binding can create asymmetry in the exon inclu-
sion pathways. RNA splicing maps indicate that protein–
RNA interactions in the vicinity of alternative exons most
often enhance downstream intron splicing or silence up-
stream intron splicing (Figure 2). This asymmetric effect
could create a restricted competitive situation for alterna-
tive cassette exons, where only the downstream intron
splicing competes with the exon skipping pathway
(Figure 4a). In situations of such restricted competition,
RBP binding would be necessary to promote exon inclusion
by enhancing the downstream intron splicing pathway
(Figure 4b).
Asymmetric splicing decision making could play a role
in the previously described models. For instance, slow
transcriptional elongation promotes the splicing of the
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Figure 4. Asymmetric splicing decision making. Splicing decisions for cassette exons (green box) are the result of the exon skipping (blue line) pathway competing with two
exon inclusion (red lines) pathways. RNA splicing maps indicate that RBPs often enhance splicing by binding to the downstream intron. As a result, these RBPs
asymmetrically enhance the downstream intron removal pathway of exon inclusion. In this schematic example, RBP (red ellipse) assembly on the nascent transcript
promotes the pathway where the downstream intron is spliced first. (a) In the absence of sufficient RBP activity, perhaps because of fast splicing kinetics reducing the
temporal window for RBP assembly, the exon skipping pathway dominates the competition. (b) Slower splicing kinetics might allow the increased binding of SR proteins
(black ellipse) to the exon, and other RBPs downstream of the exon that promote stable U1 snRNP (yellow ellipse) binding to the 50 splice site (50 SS). In this case, increased
RBP assembly enhances exon inclusion by promoting the removal of the downstream intron (red line).
Review Trends in Genetics March 2011, Vol. 27, No. 3downstream intron of fibronectin exon 33 [68,73]. Accord-
ing to the splicing kinetics model, slow transcriptional
elongation might extend the temporal window for the
assembly of RBPs on the nascent transcript. Thus, the
observed asymmetric splicing effect on the fibronectin exon
33 downstream intron splicing could be a result of the
asymmetric binding preferences of RBPs (Figure 4b). The
analysis of splicing intermediates in the chromatin fraction
has indicated that introns flanking fibronectin exon 33
were spliced faster than introns flanking either constitu-
tive exons or two other alternative exons [68]. It remains to
be seen if the fast splicing kinetics of flanking introns is a
general characteristic of exons that are sensitive to the
effects of distal RBP binding or transcriptional elongation.
Concluding remarks
We have discussed how understanding the global princi-
ples behind the regulation of alternative splicing can
provide insights into the mechanisms of splicing regula-
tion. To date, RNA splicing maps have only been deter-
mined for individual RBPs. It is clear, however, from
individual alternative exons that their splicing is regulat-
ed by multiple RBPs acting either competitively or coop-
eratively [74,75]. The high resolution of iCLIP (Box 1)
makes this method particularly suited for combinatorial
studies of multiple RBPs [40]. Building combinatorial
RNA splicingmaps to identify relations between the inter-
actions of multiple proteins with proximal sites on the
same RNA and under conditions that influence these
regulatory interactions could greatly increase our under-
standing of combinatorial splicing regulation across the
genome.
The development of RNA splicing maps from the com-
bination of genome-wide protein–RNA interaction data
with splicing profiles has allowed broad, position-based
principles for splicing regulation to be inferred for a few
RBPs. As the resolution and quantitative capacity of thesemethods improves with the development of iCLIP and
RNA-seq, the ability to define these rules becomes more
precise. At the same time, precise definition of these rules
will help identify exons and RBPs that deviate from the
basic splicing models. These deviations will help us better
understand how multiple variables contribute to the regu-
lation of splicing. To understand such integrated regula-
tion, RNA splicing maps will need to be combined with
analyses of other variables that contribute to alternative
splicing decisions, such as splicing kinetics, transcriptional
elongation speed, chromatin, the post-translational mod-
ifications of RBPs, RNA structure and the interactions of
pre-mRNA with other noncoding RNAs. Finally, biochem-
ical and kinetic studies of the insights gained from genome-
wide analyses will be required to fully understand the
mechanisms of splicing regulation.
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